Loading...
Treatment Outcomes for Patients Undergoing Hemodialysis with Chronic Hepatitis C on the Sofosbuvir and Daclatasvir Regimen
Background Hepatitis C (HCV) infection is the most commonly acquired infection for patients on hemodialysis and is associated with significant morbidity and disease progression. Direct-acting antivirals (DAAs) have revolutionized the management of HCV. However, limited data exist regarding their eff...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823026/ https://ncbi.nlm.nih.gov/pubmed/31720170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5702 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|